DUBLIN–(BUSINESS WIRE)–The “Eye Care Market Trends in China” report has been added to ResearchAndMarkets.com’s offering. In the two past decades, the market has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities an…
Author: Business Wire
Contact Lense Market Trends in China (2018-2027) – CAGR to Grow at 8% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lense Market Trends in China” report has been added to ResearchAndMarkets.com’s offering. In the two past decades, the market has been growing at a fast pace. The dramatic expansions of the manufacturing capabiliti…
ABOM Announces Sales Alliance with Essilor Prescription Safety Eyewear for RX with Advanced Anti-Fog Technology
PORTLAND, Ore.–(BUSINESS WIRE)–ABOM Announces Sales Alliance with Essilor Prescription Safety Eyewear for RX with Advanced Anti-Fog Technology
U.S. Online Eyewear Market Analysis, Trends, Size & Forecasts 2015-2025, With the Value of the Market to Rise to $505.4 Million by 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “U.S. Online Eyewear Market Size and Forecast by Type (Eye Glasses, Contact Lens), and Trend Analysis, 2015-2025” report has been added to ResearchAndMarkets.com’s offering. The U.S. online eyewear market is expected to rea…
SeniorWell Partners with PracticeEHR
CHICAGO–(BUSINESS WIRE)–SeniorWell, a mobile healthcare company, today announced its partnership with PracticeEHR.
Europe Dry Eye Market 2018 – Epidemiology & Patient Flow Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Eye Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. This research provides insights into Dry Eye epidemiology, Dry Eye diagnosed patients, and Dry Eye t…
Ocular Therapeutix™ Announces NDA Resubmission of DEXTENZA™
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company’s New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate DEXTENZA™ (dexamethasone insert) 0.4mg, for the treatment of ocular pain following ophthalmic surgery. The resubmiss
Global Ophthalmoscopes Market Analysis, Trends & Forecasts 2018-2022, With an Expected CAGR of 5.82% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmoscopes Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The analysts forecast the global ophthalmoscopes market to grow at a CAGR of 5.82% during the period 2018-2022. Ophthalmo…
BioTime Awarded Grant From the NIH
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has been awarded a grant of $743,345 from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH). This award constitutes the second-year funding of a $1.6 million SBIR grant to advance BioTime’s innovative, next generation retinal restoration program addressing advanced retinal diseases an
Blue Shield of California Announces Sandra Clarke as Senior Vice President and Chief Financial Officer and Jeff Semenchuk as Senior Vice President and Chief Innovation Officer
SAN FRANCISCO–(BUSINESS WIRE)–Blue Shield of California announced today two new selections to the company’s senior leadership team.
Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand
HEIDELBERG, Germany–(BUSINESS WIRE)–#AFT–Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, announced that NovaTears®, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD), is now also available in Australia. Dry eye is a chronic condition affecting about one third of Australian adults and half of those aged over 50. At a minimum, dry e
Global Cataract Surgery Devices Market Analysis & Forecasts 2018-2022, With an Expected CAGR of 3.42% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cataract Surgery Devices Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The analysts forecast the Global cataract surgery devices market to grow at a CAGR of 3.42% during the period 20…
Global Ophthalmic Instrumentation Strategic Business Report 2018-2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Instrumentation – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. This report analyzes the worldwide markets in Units and US$ Thousand by the following Segments: Diagnostic Devices (OCT S
HeartFlow Announces New Commercial Coverage With UnitedHealthcare, Largest Health Insurer in U.S.
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45 million beneficiaries.
Oyster Point Pharma Announces FDA Clearance of Investigational New Drug Application for the Treatment of Dry Eye Disease
PRINCETON, N.J.–(BUSINESS WIRE)–#DryEye–Oyster Point Pharma Announces FDA Clearance of Investigational New Drug Application for the Treatment of Dry Eye Disease.
Innovations in Eye Disease Diagnosis, Thermal Imaging, Breast Cancer Diagnosis, Malaria Diagnosis, Stroke Detection, and MRI, 2018 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Innovations in Eye Disease Diagnosis, Thermal Imaging, Breast Cancer Diagnosis, Malaria Diagnosis, Stroke Detection, and MRI” report has been added to ResearchAndMarkets.com’s offering. The latest issue of Medical Imaging …
Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Age-Related Macular Degeneration epidem…
OneLegacy to Host Nation’s Largest Donation and Transplantation Symposium October 30 in Pomona
LOS ANGELES–(BUSINESS WIRE)–#donatelife–OneLegacy will host its ninth annual “Donation & Transplantation Symposium” October 30 at the Sheraton Fairplex Hotel and Convention Center in Pomona.
Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO) (“Aerpio”) today announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018, following its previously announced approval to list its common stock on the Nasdaq Capital Market. Aerpio also announced today the pricing of the previously announced underwritten public offering of 11,688,000 shares of its common stock at a price to the public o
EyeQue Raises $11.2 Million in Series B to Bring At-Home Vision Testing to the Masses
NEWARK, Calif.–(BUSINESS WIRE)–#AtHomeVisionTesting–EyeQue has raised $11.2 million dollars in Series B investment to further fuel the mission of bringing affordable at-home vision tests to the masses.